| Report ID | 281715 |
| Drug Identification Number | 02405997 |
| Brand name | RIVA-ATOMOXETINE |
| Common or Proper name | Riva-Atomoxetine 40mg |
| Company Name | LABORATOIRE RIVA INC. |
| Market Status | MARKETED |
| Active Ingredient(s) | ATOMOXETINE |
| Strength(s) | 40MG |
| Dosage form(s) | CAPSULE |
| Route of administration | ORAL ORAL |
| Packaging size | 30 |
| Anatomical Therapeutical Chemical (ATC) code | N06BA |
| Anatomical Therapeutical Chemical (ATC) description | PSYCHOSTIMULANTS AND NOOTROPICS |
| Reason for discontinuation | Business reasons |
| Anticipated discontinuation date | 2025-10-08 |
| Actual discontinuation date | 2025-10-08 |
| Remaining supply date | |
| Discontinuation status | Discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 660 BOUL. INDUSTRIEL BLAINVILLE, QUEBEC CANADA J7C 3V4 |
| Company contact information |
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2026-03-27 | French | Compare |
| v1 | 2026-03-27 | English | Compare |
Showing 1 to 2 of 2